SCHEMBL9724874

SCHEMBL9724874

Cc1cc2c(c(C)c1[N+](=O)[O-])OCO2

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TXNRD1 Q16881 1/20 0.49
TXNRD3 Q86VQ6 1/20 0.49
TXNRD2 Q9NNW7 1/20 0.49
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
MAPT P10636 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
POLB P06746 2/20 0.40
MCL1 Q07820 1/20 0.40
NQO2 P16083 2/20 0.38
ALDH1A1 P00352 5/20 0.37
TDP1 Q9NUW8 2/20 0.37
BLM P54132 1/20 0.36
CYP19A1 P11511 1/20 0.34
SRC P12931 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17659883 0.81 TXNRD1 (0.50) TXNRD1TXNRD3TXNRD2KMT2AMEN1
SCHEMBL8403277 0.75 ALDH1A1 (0.43) TXNRD1TXNRD3TXNRD2KMT2AMEN1
SCHEMBL5239589 0.75 TXNRD1 (0.68) TXNRD1TXNRD3TXNRD2KMT2AMEN1
SCHEMBL12341984 0.74 NQO2 (0.42) POLBNQO2ALDH1A1CYP19A1SMN1; SMN2
SCHEMBL1028694 0.72 MAPT (0.62) TXNRD1TXNRD3TXNRD2KMT2AMEN1
SCHEMBL4918988 0.71 TDP1 (0.52) KMT2AMEN1MAPTL3MBTL1ALDH1A1
SCHEMBL17659043 0.71 MAPT (0.50) TXNRD1TXNRD3TXNRD2KMT2AMEN1
SCHEMBL8403300 0.71 TXNRD1 (0.68) TXNRD1TXNRD3TXNRD2KMT2AMEN1
SCHEMBL30330095 0.71 CYP1A2 (0.51) TXNRD1TXNRD3TXNRD2KMT2AMEN1
SCHEMBL17241149 0.71 TXNRD1 (0.47) TXNRD1TXNRD3TXNRD2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5082848-A Gastrointestinal disorders SMITH KLINE & FRENCH LABORATORIES, LTD. (GB) 1992-01-21 US disclosed
EP-0331357-A1 4-Amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion SMITHKLINE BECKMAN INTERCREDIT B.V. (NL) 1989-09-06 EP disclosed